Discriminant analysis of asbestiform and non-asbestiform amphibole particles and its implications for toxicological studies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discriminant analysis of asbestiform and non-asbestiform amphibole particles and its implications for toxicological studies
Authors
Keywords
Asbestiform, Non-asbestiform, Discriminant analysis, Amphibole, Mesothelioma, Lung cancer
Journal
Computational Toxicology
Volume -, Issue -, Pages 100233
Publisher
Elsevier BV
Online
2022-06-02
DOI
10.1016/j.comtox.2022.100233
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dimensional characteristics of the major types of amphibole mineral particles and the implications for carcinogenic risk assessment
- (2022) Andrey A. Korchevskiy et al. INHALATION TOXICOLOGY
- Modeling mesothelioma risk factors from amphibole fiber dimensionality: mineralogical and epidemiological perspective
- (2020) Ann G. Wylie et al. JOURNAL OF APPLIED TOXICOLOGY
- Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted/banned asbestos use
- (2020) Naomi Alpert et al. Translational Lung Cancer Research
- Characterization of Fibrous Mordenite: A First Step for the Evaluation of Its Potential Toxicity
- (2020) Dario Di Giuseppe Crystals
- Dimensions of elongated mineral particles: a study of more than 570 fibers from more than 90 cases with implications for pathogenicity and classification as asbestiform vs. cleavage fragments
- (2019) Victor L. Roggli et al. ULTRASTRUCTURAL PATHOLOGY
- Mesothelioma and other lung disease in taconite miners; the uncertain role of non-asbestiform EMP
- (2018) Jeffrey H. Mandel et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Measurement of elongate mineral particles: What we should measure and how do we do it?
- (2018) Eric J. Chatfield TOXICOLOGY AND APPLIED PHARMACOLOGY
- A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans
- (2018) David H. Garabrant et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Asbestos fiber length and its relation to disease risk
- (2017) Christy A. Barlow et al. INHALATION TOXICOLOGY
- Amphibole Dusts: Fibers, Fragments, and Mesothelioma
- (2016) Ann G. Wylie CANADIAN MINERALOGIST
- Thoracic and respirable particle definitions for human health risk assessment
- (2013) James S Brown et al. Particle and Fibre Toxicology
- Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile
- (2009) D. Loomis et al. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- A Meta-Analysis of Asbestos-Related Cancer Risk That Addresses Fiber Size and Mineral Type
- (2008) D. Wayne Berman et al. CRITICAL REVIEWS IN TOXICOLOGY
- Differentiating Amphibole Asbestos from Non-Asbestos in a Complex Mineral Environment
- (2008) D.R. Van Orden et al. INDOOR AND BUILT ENVIRONMENT
- Identification and enumeration of asbestos fibers in the mining environment: Mission and modification to the Federal Asbestos Standard
- (2008) Arthur M. Langer REGULATORY TOXICOLOGY AND PHARMACOLOGY
- An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments
- (2007) John F. Gamble et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassays
- (2007) Brooke T. Mossman REGULATORY TOXICOLOGY AND PHARMACOLOGY
- The mineral nature of asbestos
- (2007) Malcolm Ross et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now